Market View

WHO’s advice against Gilead’s remdesivir and rising coronavirus cases put a dent on major North American indices. US Treasury ends several crisis-fighting programs, chopping the Fed’s lending power. British trade minister Liz Truss announced that Britain is determined to reach a trade deal with Canada before the end of the year. The Canadian dollar was 76.55. U.S. S&P500 ended the week down 0.8%, while the TSX ended the week up 1.1%.

It was another mixed week, this time with technology gaining 6.0%, financials 3.0%, and energy 2.4%. Materials slipped 3.2%, and consumer staples fell by 2.2%. Healthcare and industrials ended the week flat. The most heavily traded shares by volume were Bombardier Inc, Manulife Financial, and Cenovus Energy.

5 from 5i

Here are five reads we found interesting last week:

• What happens when high yield becomes low yield? Written by Charlie Bilello of Compound Advisors
• Inside Affirm’s IPO filing: A look at its economics, profits and revenue concentration, by Alex Wilhelm of TechCrunch
• The Sharpe ratio broke investors’ brains, by Richard Wiggins of Institutional Investor
• ETFs moving beyond passive roots, by Cinthia Murphy of ETF.com
• Can bond funds repel the indexers? Authored by John Rekenthaler of Morningstar

Happy Reading & Stay Safe!

Thinking about becoming a 5i Research Member?  

There is no better time to join but don't just take our word for it. Try it for free for the next month and experience all the benefits of the 5i Research membership. (And don't worry. We won't ask for your credit card upfront)

Disclosure: Please note that the author does not hold a financial or other interest stocks or funds mentioned.